Status:
COMPLETED
Association Between Irisin, Inflammatory Markers and Metabolic Status in Obese Children With Type 2 Diabetes Mellitus
Lead Sponsor:
Instituto Tecnologico y de Estudios Superiores de Monterey
Conditions:
Diabetes Mellitus, Type 2
Pediatric Obesity
Eligibility:
All Genders
6-17 years
Brief Summary
The objective of this study was to investigate the association of irisin with inflammatory markers as well with metabolic and anthropometric parameters in children and adolescents with type 2 diabetes...
Detailed Description
Mexican children and adolescents previously diagnosed with type 2 diabetes mellitus according to the American Diabetes Association (ADA) criteria were recruited and compared to healthy controls. The ...
Eligibility Criteria
Inclusion
- • Have been previously diagnosed with T2DM according to the American Diabetes Association (ADA) criteria .
- Healthy controls were required to have:
- Normal weight according to the Centers for Disease Control and Prevention (CDC) criteria.
- No metabolic abnormalities on blood samples
- No previously diagnosed cardiometabolic diseases
- Not been using antihypertensive, lipid or glucose lowering medications
Exclusion
- Disapproval by the children's physician due to any at-risk medical condition known by the parents
- Use of drugs for high blood pressure, hyperglycemia, or dyslipidemia
Key Trial Info
Start Date :
January 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2017
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03767608
Start Date
January 1 2016
End Date
January 1 2017
Last Update
December 6 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Nutrition and Obesity Research Center. School of Medicine, TEC Salud, Tecnológico de Monterrey
Monterrey, Nuevo León, Mexico, 64710